FDA Inspection
Wyeth Pharmaceutical Division of Wyeth Holdings LLCWyeth Pharmaceutical Division of Wyeth Holdings LLC – FDA Inspection, Apr 19, 2018
Record Details
This FDA Inspection record concerns Wyeth Pharmaceutical Division of Wyeth Holdings LLC, with an inspection on April 19, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 19, 2018
- Product Type
- Biologics
- People
- Burnell M. Henry (FDA Associated Person)
- Omotunde O. Osunsanmi (Issuing Officer)
View Company Profile
ID · 277e2e29-db7e-420f-b95d-b8fe933f6387
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1051716
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Wyeth Pharmaceutical Division of Wyeth Holdings LLC
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2026 | Not classified | Atlanta District Office | Human Cellular, Tissue, and Gene Therapies |
| October 17, 2024 | Not classified | Atlanta District Office | |
| November 10, 2023 | Not classified | Atlanta District Office | |
| November 18, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 26, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- FDA Inspection 1305396 - 2026-04-23
- FDA Inspection 1252280 - 2024-10-17
- FDA Inspection 1234989 - 2023-11-10
- FDA Inspection 1192736 - 2022-11-18
- FDA Inspection 1121288 - 2019-11-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.